|
Molecular properties generated using the CDK |
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
2-[4-[3-[2-(trifluoromethyl)thioxanthen-9-ylidene]propyl]piperazin-1-yl]ethanol |
International Nonproprietary Names ![]() |
|
INN number | INN |
1745 | flupentixol |
Synonyms ![]() |
(E)-flupenthixol | beta-flupenthixol | flupentixol hydrochloride | trans-(E)-flupentixol |
Comments |
This is the trans molecular form of the approved drug flupentixol, which is the cis form. Trans-flupentixol has lower affinity than cis-flupentixol for the dopamine D2 and D3 receptors [1]. |
Database Links ![]() |
|
BindingDB Ligand | 50026957 |
CAS Registry No. | 53772-85-3 (source: Scifinder) |
ChEMBL Ligand | CHEMBL42055 |
DrugBank Ligand | DB00875 |
GtoPdb PubChem SID | 135651274 |
PubChem CID | 5281878 |
Search Google for chemical match using the InChIKey | NJMYODHXAKYRHW-BLLMUTORSA-N |
Search Google for chemicals with the same backbone | NJMYODHXAKYRHW |
Search PubMed clinical trials | flupentixol |
Search PubMed titles | flupentixol |
Search PubMed titles/abstracts | flupentixol |
Search UniChem for chemical match using the InChIKey | NJMYODHXAKYRHW-BLLMUTORSA-N |
Search UniChem for chemicals with the same backbone | NJMYODHXAKYRHW |
Wikipedia | Flupentixol |